OCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy

Efstratia Amaxilati, Christos Bakirtzis, Angeliki Fountouki, Chrysoula Koutsiouki, Demetrios Pirounides

Open source

DOI
10.3389/fmed.2026.1880872
Published
2026-07-31
Container
Frontiers in Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1880872,
  title = {OCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy},
  author = {Efstratia Amaxilati and Christos Bakirtzis and Angeliki Fountouki and Chrysoula Koutsiouki and Demetrios Pirounides},
  year = {2026},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2026.1880872},
  url = {https://doi.org/10.3389/fmed.2026.1880872}
}

RIS

TY  - JOUR
TI  - OCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy
AU  - Efstratia Amaxilati
AU  - Christos Bakirtzis
AU  - Angeliki Fountouki
AU  - Chrysoula Koutsiouki
AU  - Demetrios Pirounides
PY  - 2026
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1880872
UR  - https://doi.org/10.3389/fmed.2026.1880872
ER  - 

APA

Amaxilati, E., Bakirtzis, C., Fountouki, A., Koutsiouki, C., & Pirounides, D. (2026). OCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1880872

Source records